Conmed Corp. Forecast, price target & analysts
Conmed Corp. Target price 2025 - Analyst rating & recommendation
Conmed Corp. Classifications & Recommendation:
Conmed Corp. Price Target
| Target Price | $74.43 |
| Price | $50.84 |
| Potential |
46.40%
register free of charge
|
| Number of Estimates | 7 |
|
7 Analysts have issued a price target Conmed Corp. 2026 .
The average Conmed Corp. target price is $74.43.
This is
46.40%
register free of charge
$91.00
78.99%
register free of charge
$55.00
8.18%
register free of charge
|
|
| A rating was issued by 7 analysts: 2 Analysts recommend Conmed Corp. to buy, 5 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Conmed Corp. stock has an average upside potential 2026 of
46.40%
register free of charge
|
Sales and Margin forecast 2025, 2026 & 2027
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Billion $ | 1.30 | 1.36 |
| 4.98% | 4.19% | |
| EBITDA Margin | 16.54% | 20.22% |
| 12.69% | 22.22% | |
| Net Margin | 10.08% | 9.50% |
| 98.45% | 5.76% |
7 Analysts have issued a sales forecast Conmed Corp. 2025 . The average Conmed Corp. sales estimate is
This results in the following potential growth metrics:
6 Analysts have issued an Conmed Corp. EBITDA forecast 2025. The average Conmed Corp. EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
4 Conmed Corp. Analysts have issued a net profit forecast 2025. The average Conmed Corp. net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 & 2027
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | 4.25 | 4.18 |
| 108.33% | 1.65% | |
| P/E | 12.18 | |
| EV/Sales | 1.84 |
4 Analysts have issued a Conmed Corp. forecast for earnings per share. The average Conmed Corp. EPS is
This results in the following potential growth metrics and future valuations:
Current Conmed Corp. Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Stifel |
Locked
➜
Locked
|
Locked | Apr 28 2025 |
| JP Morgan |
Locked
➜
Locked
|
Locked | Feb 06 2025 |
| Needham |
Locked
➜
Locked
|
Locked | Feb 06 2025 |
| Stifel |
Locked
➜
Locked
|
Locked | Feb 06 2025 |
| Wells Fargo |
Locked
➜
Locked
|
Locked | Feb 06 2025 |
| Needham |
Locked
➜
Locked
|
Locked | Oct 31 2024 |
| Needham |
Locked
➜
Locked
|
Locked | Oct 04 2024 |
| Analyst Rating | Date |
|---|---|
|
Locked
Stifel:
Locked
➜
Locked
|
Apr 28 2025 |
|
Locked
JP Morgan:
Locked
➜
Locked
|
Feb 06 2025 |
|
Locked
Needham:
Locked
➜
Locked
|
Feb 06 2025 |
|
Locked
Stifel:
Locked
➜
Locked
|
Feb 06 2025 |
|
Locked
Wells Fargo:
Locked
➜
Locked
|
Feb 06 2025 |
|
Locked
Needham:
Locked
➜
Locked
|
Oct 31 2024 |
|
Locked
Needham:
Locked
➜
Locked
|
Oct 04 2024 |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
